SE9801287D0 - Incorporation of active substances in carrier matrixes - Google Patents

Incorporation of active substances in carrier matrixes

Info

Publication number
SE9801287D0
SE9801287D0 SE9801287A SE9801287A SE9801287D0 SE 9801287 D0 SE9801287 D0 SE 9801287D0 SE 9801287 A SE9801287 A SE 9801287A SE 9801287 A SE9801287 A SE 9801287A SE 9801287 D0 SE9801287 D0 SE 9801287D0
Authority
SE
Sweden
Prior art keywords
incorporation
active substances
carrier matrixes
carrier
matrixes
Prior art date
Application number
SE9801287A
Other languages
English (en)
Swedish (sv)
Inventor
Marie-Louise Andersson
Catherine Boissier
Anne Marie Juppo
Anette Larsson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9801287A priority Critical patent/SE9801287D0/xx
Publication of SE9801287D0 publication Critical patent/SE9801287D0/xx
Priority to TW088105268A priority patent/TW542724B/zh
Priority to ZA9902549A priority patent/ZA992549B/xx
Priority to ARP990101561A priority patent/AR019262A1/es
Priority to PL99344077A priority patent/PL344077A1/xx
Priority to AT99924076T priority patent/ATE329580T1/de
Priority to SI9930906T priority patent/SI1069890T1/sl
Priority to DE69931904T priority patent/DE69931904T2/de
Priority to AU40663/99A priority patent/AU744874B2/en
Priority to JP2000543117A priority patent/JP2002511400A/ja
Priority to ES99924076T priority patent/ES2267268T3/es
Priority to PT99924076T priority patent/PT1069890E/pt
Priority to EEP200000595A priority patent/EE200000595A/xx
Priority to CNB998050318A priority patent/CN1201728C/zh
Priority to CA002327522A priority patent/CA2327522C/en
Priority to RU2000125873/14A priority patent/RU2208435C2/ru
Priority to KR1020007011361A priority patent/KR100600691B1/ko
Priority to IL13863599A priority patent/IL138635A0/xx
Priority to PCT/SE1999/000583 priority patent/WO1999052507A1/en
Priority to IDW20001991A priority patent/ID29286A/id
Priority to EP99924076A priority patent/EP1069890B1/en
Priority to BR9909636-6A priority patent/BR9909636A/pt
Priority to US09/297,440 priority patent/US6372260B1/en
Priority to CZ20003784A priority patent/CZ20003784A3/cs
Priority to NZ507190A priority patent/NZ507190A/en
Priority to HU0102305A priority patent/HUP0102305A3/hu
Priority to DK99924076T priority patent/DK1069890T3/da
Priority to SK1411-2000A priority patent/SK14112000A3/sk
Priority to TR2000/02960T priority patent/TR200002960T2/xx
Priority to IS5656A priority patent/IS5656A/is
Priority to NO20005150A priority patent/NO329145B1/no
Priority to CY20061101138T priority patent/CY1105154T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/04—Solvent extraction of solutions which are liquid
    • B01D11/0403—Solvent extraction of solutions which are liquid with a supercritical fluid
    • B01D11/0411—Solvent extraction of solutions which are liquid with a supercritical fluid the supercritical fluid acting as solvent for the solvent and as anti-solvent for the solute, e.g. formation of particles from solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
    • Y10T428/2985—Solid-walled microcapsule from synthetic polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Nozzles (AREA)
SE9801287A 1998-04-14 1998-04-14 Incorporation of active substances in carrier matrixes SE9801287D0 (sv)

Priority Applications (32)

Application Number Priority Date Filing Date Title
SE9801287A SE9801287D0 (sv) 1998-04-14 1998-04-14 Incorporation of active substances in carrier matrixes
TW088105268A TW542724B (en) 1998-04-14 1999-04-02 Incorporation of active substances in carrier matrixes
ZA9902549A ZA992549B (en) 1998-04-14 1999-04-06 Incorporation of active substances in carrier matrixes.
ARP990101561A AR019262A1 (es) 1998-04-14 1999-04-06 Proceso para la preparacion de una formulacion que comprende una sustancia activa o sustancias activas asociadas con un portador, y formulacion preparadapor dicho proceso.
TR2000/02960T TR200002960T2 (tr) 1998-04-14 1999-04-09 Taşıyıcı matrislere etken maddelerin eklenmesi.
CA002327522A CA2327522C (en) 1998-04-14 1999-04-09 Incorporation of active substances in carrier matrixes
IL13863599A IL138635A0 (en) 1998-04-14 1999-04-09 Incorporation of active substances in carrier matrixes
SI9930906T SI1069890T1 (sl) 1998-04-14 1999-04-09 Vkljucitev aktivnih substanc v matriko nosilca
DE69931904T DE69931904T2 (de) 1998-04-14 1999-04-09 Einbau aktiver substanzen in trägermatrizen
AU40663/99A AU744874B2 (en) 1998-04-14 1999-04-09 Incorporation of active substances in carrier matrixes
JP2000543117A JP2002511400A (ja) 1998-04-14 1999-04-09 担体マトリックスへの活性物質の組み込み
ES99924076T ES2267268T3 (es) 1998-04-14 1999-04-09 Incorporacion de sustancias activas en matrices vehiculo.
PT99924076T PT1069890E (pt) 1998-04-14 1999-04-09 Incorporacao de substancias activas em matrizes veiculares
EEP200000595A EE200000595A (et) 1998-04-14 1999-04-09 Toimeaine viimine kandjamaatriksisse
CNB998050318A CN1201728C (zh) 1998-04-14 1999-04-09 载体基质中活性物质的掺入
PL99344077A PL344077A1 (en) 1998-04-14 1999-04-09 Incorporation of active substances in carrier matrixes
RU2000125873/14A RU2208435C2 (ru) 1998-04-14 1999-04-09 Внедрение активных веществ в матрицы носителей
KR1020007011361A KR100600691B1 (ko) 1998-04-14 1999-04-09 활성 물질의 담체 매트릭스로의 결합
AT99924076T ATE329580T1 (de) 1998-04-14 1999-04-09 Einbau aktiver substanzen in trägermatrizen
PCT/SE1999/000583 WO1999052507A1 (en) 1998-04-14 1999-04-09 Incorporation of active substances in carrier matrixes
IDW20001991A ID29286A (id) 1998-04-14 1999-04-09 Pemasukan zat-zat aktif pada matriks pembawa
EP99924076A EP1069890B1 (en) 1998-04-14 1999-04-09 Incorporation of active substances in carrier matrixes
BR9909636-6A BR9909636A (pt) 1998-04-14 1999-04-09 Processo para a preparação de uma formulação, e, formulação
US09/297,440 US6372260B1 (en) 1998-04-14 1999-04-09 Incorporation of active substances in carrier matrixes
CZ20003784A CZ20003784A3 (cs) 1998-04-14 1999-04-09 Způsob inkorporace účinných látek do matric nosičů
NZ507190A NZ507190A (en) 1998-04-14 1999-04-09 Incorporation of active substances in carrier matrixes wherein an emulsion is contacted with a fluid gas using an anti-solvent technique
HU0102305A HUP0102305A3 (en) 1998-04-14 1999-04-09 Incorporation of active substances in carrier matrixes
DK99924076T DK1069890T3 (da) 1998-04-14 1999-04-09 Inkorporering af aktive substanser i bærematrikser
SK1411-2000A SK14112000A3 (sk) 1998-04-14 1999-04-09 Začlenenie účinných látok do matríc nosiča
IS5656A IS5656A (is) 1998-04-14 2000-10-11 Innlimun virkra efna í burðarmatrixur
NO20005150A NO329145B1 (no) 1998-04-14 2000-10-13 Inkorporering av aktive substanser i baerermatriser
CY20061101138T CY1105154T1 (el) 1998-04-14 2006-08-11 Ενσωματωση δραστικων ουσιων σε μητρες ουσιων-φορεων

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9801287A SE9801287D0 (sv) 1998-04-14 1998-04-14 Incorporation of active substances in carrier matrixes

Publications (1)

Publication Number Publication Date
SE9801287D0 true SE9801287D0 (sv) 1998-04-14

Family

ID=20410946

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9801287A SE9801287D0 (sv) 1998-04-14 1998-04-14 Incorporation of active substances in carrier matrixes

Country Status (31)

Country Link
US (1) US6372260B1 (xx)
EP (1) EP1069890B1 (xx)
JP (1) JP2002511400A (xx)
KR (1) KR100600691B1 (xx)
CN (1) CN1201728C (xx)
AR (1) AR019262A1 (xx)
AT (1) ATE329580T1 (xx)
AU (1) AU744874B2 (xx)
BR (1) BR9909636A (xx)
CA (1) CA2327522C (xx)
CY (1) CY1105154T1 (xx)
CZ (1) CZ20003784A3 (xx)
DE (1) DE69931904T2 (xx)
DK (1) DK1069890T3 (xx)
EE (1) EE200000595A (xx)
ES (1) ES2267268T3 (xx)
HU (1) HUP0102305A3 (xx)
ID (1) ID29286A (xx)
IL (1) IL138635A0 (xx)
IS (1) IS5656A (xx)
NO (1) NO329145B1 (xx)
NZ (1) NZ507190A (xx)
PL (1) PL344077A1 (xx)
PT (1) PT1069890E (xx)
RU (1) RU2208435C2 (xx)
SE (1) SE9801287D0 (xx)
SK (1) SK14112000A3 (xx)
TR (1) TR200002960T2 (xx)
TW (1) TW542724B (xx)
WO (1) WO1999052507A1 (xx)
ZA (1) ZA992549B (xx)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6761909B1 (en) * 1999-12-21 2004-07-13 Rxkinetix, Inc. Particulate insulin-containing products and method of manufacture
EP1242112A4 (en) * 1999-12-21 2005-02-09 Rxkinetix Inc PRODUCTS CONTAINING MEDICINANT SUBSTANCE PARTICLES AND PROCESS FOR PREPARING THE SAME
GB0102075D0 (en) * 2001-01-26 2001-03-14 Astrazeneca Ab Process
FR2824754B1 (fr) * 2001-05-15 2004-05-28 Separex Sa Procede d'obtention de particules solides a partir d'au moins un produit hydrosoluble
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
ES2398910T3 (es) * 2001-09-28 2013-03-22 Tntgamble, Inc. Sistema de aporte para componentes biológicos
US20070098784A1 (en) 2001-09-28 2007-05-03 Nutraceutix, Inc. Delivery system for biological component
US20050048077A1 (en) * 2002-02-21 2005-03-03 George Sachs Compositions, test kits and methods for detecting helicobacter pylori
US6998051B2 (en) * 2002-07-03 2006-02-14 Ferro Corporation Particles from supercritical fluid extraction of emulsion
GB0216780D0 (en) * 2002-07-19 2002-08-28 Bradford Particle Design Ltd Methods of particle formation
US6966990B2 (en) 2002-10-11 2005-11-22 Ferro Corporation Composite particles and method for preparing
US7083748B2 (en) * 2003-02-07 2006-08-01 Ferro Corporation Method and apparatus for continuous particle production using supercritical fluid
US6931888B2 (en) 2003-02-07 2005-08-23 Ferro Corporation Lyophilization method and apparatus for producing particles
US7455797B2 (en) * 2003-02-28 2008-11-25 Ferro Corporation Method and apparatus for producing particles using supercritical fluid
US20060182808A1 (en) * 2003-04-29 2006-08-17 Akzo Nobel N.V. Antisolvent solidification process
US20060008531A1 (en) * 2003-05-08 2006-01-12 Ferro Corporation Method for producing solid-lipid composite drug particles
EP1624862B1 (en) 2003-05-08 2014-12-31 Nektar Therapeutics Particulate materials
WO2005022603A2 (en) * 2003-09-02 2005-03-10 Integral Technologies, Inc. Low cost conductive containers manufactured from conductive loaded resin-based materials
GB0602637D0 (en) 2006-02-09 2006-03-22 Glaxo Group Ltd Novel process
NL1031224C2 (nl) * 2006-02-23 2007-09-03 Friesland Brands Bv Het bereiden van gedroogde deeltjes met behulp van een superkritisch medium.
US20080095856A1 (en) * 2006-05-12 2008-04-24 Jacobson Gunilla B Encapsulated Nanoparticles for Drug Delivery
FR2900845B1 (fr) 2006-05-15 2009-03-06 Commissariat Energie Atomique Procede et dispositif de synthese de particules organiques ou inorganiques enrobees
EP1913955A1 (en) 2006-10-19 2008-04-23 Gerhard, Markus Novel method for treating H.pylori infections
US7745566B2 (en) * 2007-01-23 2010-06-29 Ferro Corporation Methods for the purification of polymers
US20080260852A1 (en) * 2007-01-23 2008-10-23 Ferro Pfanstiehl Laboratories, Inc. Supercritical fluid extraction produced by in-line homogenization
EP2425820B1 (en) 2007-02-11 2015-04-08 MAP Pharmaceuticals Inc Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
GB0711680D0 (en) 2007-06-18 2007-07-25 Prosonix Ltd Process
EP3272354A1 (en) 2016-07-20 2018-01-24 Technische Universität München Agents and methods for the prevention or treatment of h. pylori infections
KR102170146B1 (ko) * 2019-03-05 2020-10-26 서울대학교산학협력단 Pca 공정을 이용한 배양액의 결정화 장치 및 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639441A (en) * 1992-03-06 1997-06-17 Board Of Regents Of University Of Colorado Methods for fine particle formation

Also Published As

Publication number Publication date
BR9909636A (pt) 2000-12-19
RU2208435C2 (ru) 2003-07-20
PT1069890E (pt) 2006-09-29
EE200000595A (et) 2002-04-15
NO20005150L (no) 2000-12-08
DE69931904T2 (de) 2006-12-21
AR019262A1 (es) 2002-02-13
SK14112000A3 (sk) 2001-07-10
EP1069890A1 (en) 2001-01-24
US6372260B1 (en) 2002-04-16
IL138635A0 (en) 2001-10-31
CY1105154T1 (el) 2010-03-03
EP1069890B1 (en) 2006-06-14
NO20005150D0 (no) 2000-10-13
PL344077A1 (en) 2001-09-24
HUP0102305A2 (hu) 2001-12-28
IS5656A (is) 2000-10-11
ZA992549B (en) 1999-10-14
NO329145B1 (no) 2010-08-30
NZ507190A (en) 2002-02-01
CN1309555A (zh) 2001-08-22
CN1201728C (zh) 2005-05-18
KR100600691B1 (ko) 2006-07-19
JP2002511400A (ja) 2002-04-16
CA2327522A1 (en) 1999-10-21
DE69931904D1 (de) 2006-07-27
KR20010042660A (ko) 2001-05-25
HUP0102305A3 (en) 2003-04-28
ES2267268T3 (es) 2007-03-01
CZ20003784A3 (cs) 2001-08-15
WO1999052507A1 (en) 1999-10-21
ATE329580T1 (de) 2006-07-15
DK1069890T3 (da) 2006-08-28
TR200002960T2 (tr) 2000-12-21
AU744874B2 (en) 2002-03-07
AU4066399A (en) 1999-11-01
TW542724B (en) 2003-07-21
CA2327522C (en) 2008-03-25
ID29286A (id) 2001-08-16

Similar Documents

Publication Publication Date Title
SE9801287D0 (sv) Incorporation of active substances in carrier matrixes
NO976029D0 (no) Inhaleringsinnretning og fremgangsmåte
TR200100922T2 (tr) Aktif maddelerin akciğerler yolu ile tatbik edilmesi.
ES2143500T3 (es) Metodo y aparato para comunicar señales.
BR9612864B1 (pt) dispositivo adaptado para utilização dentro de um sistema de guia de programa eletrÈnico e método de utilização do mesmo.
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
DE69605184D1 (de) Verabreichung einer substanz in den mund
DE69114649T2 (de) In-line Gas/Flüssigkeitsdispersion.
TR200101887T2 (tr) Sıvı faz içindeki bir maddenin plastik taneleri içerisine sürekli olarak içeri zerk edilmesine mahsus metod ve alet.
DE59610469D1 (de) Vorrichtung zur Verabreichung von Substanzen, insbesondere Inhalationspräparate
AP9901607A0 (en) Method and apparatus for continuous flow isoelectric focusing for
ATE354544T1 (de) Verhinderung des zellwachstums in einem gewässer
FR2734923B1 (fr) Lame elastique, dispositif de developpement l'utilisant et procede pour sa fabrication
FI940575A (fi) Tiivistystekniikka
DE69934777D1 (de) Substanz aktivirendes verfahren-und vorrichtung
MY133463A (en) Apparatus and method for measuring ammonia in biochemical processes
DE29515869U1 (de) Vorrichtung zur gesteuerten bargeldlosen Abgabe von elektrischer Energie, Gas, Wasser oder ähnlichen Medien
AU7501996A (en) Testing of fluid systems
GR940100467A (el) Συστημα εκτελεσης ανοσοπροσδιορισμων σε βιολογικα υγρα ανθρωπων ζωων και φυτων με τριχοειδη σωληναρια.
DE59300758D1 (de) Vorrichtung zur Gaseintragung in Flüssigkeiten.
DE69431211D1 (de) Vulkanisationsverfahren und vorrichtung.
DE69023327T2 (de) Ablöseentwicklungsverfahren und Vorrichtung zur Durchführung.
DK0929294T3 (da) Fremgangsmåde til fremstilling af lavt doserede fritflydende og/eller direkte komprimerbare pulversystemer
DE29511334U1 (de) Vorrichtung zur Verabreichung von Substanzen, insbesondere Inhalationspräparaten
ID28174A (id) Turunan 5-imino-13-deoksi antrasiklin, penggunaannya, dan proses pembuatannya